Cartesian Therapeutics (RNAC) Non Operating Income (2015 - 2026)
Cartesian Therapeutics (RNAC) reported Non Operating Income of -$3000.0 for Q1 2026, down 100.07% year-over-year from $4.2 million in Q1 2025, and down 100.08% quarter-over-quarter from $3.9 million in Q4 2025.
Cartesian Therapeutics (RNAC) Non Operating Income (2015 - 2026) Analysis & Trends
Cartesian Therapeutics (RNAC) has 12 years of Non Operating Income data on file, last reported at -$3000.0 in Q1 2026.
- Non Operating Income for Q1 2026 came in at -$3000.0, down 100.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.9 million (up 113.21% YoY), and the FY2025 annual result was $3.9 million, up 111.76% from the prior year.
- Non Operating Income declined to -$3000.0 in Q1 2026 per RNAC's latest filing, from $3.9 million in the prior quarter.
- Over five years, Non Operating Income peaked at $4.2 million in Q1 2025 and troughed at -$34.3 million in Q4 2024.
- A 5-year average of -$1.6 million and a median of $245000.0 in 2023 frame the typical range for Non Operating Income.
- The sharpest annual moves came in 2023 and 2024: Non Operating Income jumped 25200.0% in 2023, then slumped 55206.45% in 2024.
- A 5-year view of Non Operating Income shows it stood at $175000.0 in 2022, then tumbled by 135.43% to -$62000.0 in 2023, then tumbled by 55206.45% to -$34.3 million in 2024, then jumped by 111.42% to $3.9 million in 2025, then tumbled by 100.08% to -$3000.0 in 2026.
- Business Quant data shows RNAC's Non Operating Income at -$3000.0 in Q1 2026, $3.9 million in Q4 2025, and -$5000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Cartesian Therapeutics | 261.84 Mn | 261.84 Mn | - | -3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | 3.92 Mn |
| Jun 30, 2025 | -5,000.00 |
| Mar 31, 2025 | 4.18 Mn |
| Dec 31, 2024 | -34.29 Mn |
| Sep 30, 2024 | 250,000.00 |
| Jun 30, 2024 | 292,000.00 |
| Mar 31, 2024 | 508,000.00 |
| Dec 31, 2023 | -62,000.00 |
| Sep 30, 2023 | 253,000.00 |
| Jun 30, 2023 | 245,000.00 |
| Mar 31, 2023 | 255,000.00 |
| Dec 31, 2022 | 175,000.00 |
| Sep 30, 2022 | 1,000.00 |
| Mar 31, 2022 | 154,000.00 |
| Sep 30, 2021 | 9,000.00 |
| Jun 30, 2021 | 6,000.00 |
| Dec 31, 2020 | 26,000.00 |
| Sep 30, 2020 | 5,000.00 |
| Jun 30, 2020 | 59,000.00 |